Delivery Order SPE2DB24D2106-SPE2DB25FAWAJ
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,441.24 by the Defense Logistics Agency on July 30, 2025. The delivery order is for MENVEO A-C-Y-W Kit (2 Vials), a meningococcal vaccine product, with an ultimate completion date of July 31, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis in the federal...
- This is a $1,080.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the MENVEO VACCINE VL 5S medical product, with an ultimate completion date of June 17, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
- Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a $6,236.64 firm fixed price delivery order to supply one vial of MENVEO, a meningococcal vaccine. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with Defense Logistics Agency to provide various pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS...
- This delivery order awards $2,075.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine product. The Defense Logistics Agency issued this firm fixed-price delivery order on July 25, 2025, with an ultimate completion date of July 28, 2025. The award carries no set-aside designation, and performance will occur at the contractor's Park Ridge, Illinois location. This...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,837.40, is for the delivery of 4,567,454,051 units of the Menveo A-C-Y-W-135 diphtheria vaccine in 0.5 ml vials. The contract has an ultimate completion date of March 5, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,676.34, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of May 8, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This $27,477.72 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $25,942.32 for the supply of Menveo A-C-Y-W immunization kits. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of MENVEO A-C-Y-W vaccines, with a ceiling value of $3,603.10 and a period of performance through April 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,603.40 for meningococcal group pharmaceutical products. This delivery order was issued on August 14, 2025, with an ultimate completion date of the same day, and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWAJDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $4,947.96 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine. The contract, which carries an ultimate completion date of August 15, 2025, was issued without a set-aside designation. Performance will take place in Conshohocken, Pennsylvania. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for comprehensive pharmaceutical and medical supply needs across Department of Defense healthcare facilities. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of contract awards with the DLA encompassing prescription medications, biologics, vaccines, and specialized medical consumables. The company's federal contracting experience demonstrates consistent capability in delivering diverse pharmaceutical products to military and federal healthcare systems nationwide. The Menveo vaccine delivery under this order supports the DLA's mission to maintain adequate immunization supplies for defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 8/14/25 |